Tevogen Bio Holdings Inc. (NASDAQ: TVGN) is -93.71% lower on its value in year-to-date trading and has touched a low of $0.65 and a high of $21.09 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TVGN stock was last observed hovering at around $0.69 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.70, the stock is -8.13% and -16.30% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.85 million and changing 1.43% at the moment leaves the stock -89.16% off its SMA200. TVGN registered -93.20% loss for a year compared to 6-month loss of -93.69%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -14.54% gain in the last 1 month and extending the period to 3 months gives it a -71.43%, and is 2.04% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.11% over the week and 11.21% over the month.
Tevogen Bio Holdings Inc. (TVGN) has around 17 employees, a market worth around $116.96M and $0.00M in sales. Distance from 52-week low is 7.18% and -96.68% from its 52-week high.
The shares outstanding are 167.11M, and float is at 16.45M with Short Float at 1.26%.
Tevogen Bio Holdings Inc. (TVGN) Insider Activity
The most recent transaction is an insider purchase by Desai Kirti, the company’s Chief Financial Officer. SEC filings show that Desai Kirti bought 3,000 shares of the company’s common stock on Jun 12 ’24 at a price of $0.82 per share for a total of $2460.0. Following the purchase, the insider now owns 9.7 million shares.
Tevogen Bio Holdings Inc. disclosed in a document filed with the SEC on Jun 05 ’24 that Saadi Ryan H. (Chief Executive Officer) bought a total of 2,607 shares of the company’s common stock. The trade occurred on Jun 05 ’24 and was made at $0.77 per share for $2000.0. Following the transaction, the insider now directly holds 118.25 million shares of the TVGN stock.
